Skip to main content

E2F4DN como agente geroterapéutico para el envejecimiento cerebral (GeroE2F4DN)

PLEC2022-009385

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i en Líneas Estratégicas
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dysfunctional serotonergic neuron-astrocyte signaling in depressive-like states

  • González-Arias, Candela
  • Sanchez-Ruiz, A.
  • Esparza, Julio
  • Sánchez-Puelles, Cristina
  • Arancibia, L.
  • Ramírez-Franco, Jorge
  • Gobbo, D.
  • Kirchhoff, Frank
  • Perea, Gertrudis
Astrocytes play crucial roles in brain homeostasis and are regulatory elements of neuronal and synaptic physiology. Astrocytic alterations have been found in Major Depressive Disorder (MDD) patients; however, the consequences of astrocyte Ca signaling in MDD are poorly understood. Here, we found that corticosterone-treated juvenile mice (Cort-mice) showed altered astrocytic Ca dynamics in mPFC both in resting conditions and during social interactions, in line with altered mice behavior. Additionally, Cort-mice displayed reduced serotonin (5-HT)-mediated Ca signaling in mPFC astrocytes, and aberrant 5-HT-driven synaptic plasticity in layer 2/3 mPFC neurons. Downregulation of astrocyte Ca signaling in naïve animals mimicked the synaptic deficits found in Cort-mice. Remarkably, boosting astrocyte Ca signaling with Gq-DREADDS restored to the control levels mood and cognitive abilities in Cort-mice. This study highlights the important role of astrocyte Ca signaling for homeostatic control of brain circuits and behavior, but also reveals its potential therapeutic value for depressive-like states., This work was supported by PID2019-106579RB-I00 and PID2022-142617NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” to G.P, by PLEC2022-009385 funded by MCIN/AEI/10.13039/501100011033 and by “NextGeneration EU/PRTR” to GP; La Marató TV3 Foundation #225619 to GP. BES-2017-080303 to CG-A and PRE2020-092999 to AS-R by MCIN/AEI/FEDER,UE. PEJ-2020-AI/BMD-18675 to LA. Deutsche Forschungsgemeinschaft (DFG) SFB 894, SFB 1158 and SPP 1757 to FK.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder

  • González-Arias, Candela
  • Perea, Gertrudis
Major depressive disorder (MDD) is a global public health concern and the leading cause of disability worldwide. It severely impairs cognitive, emotional, and social functioning, and is associated with attention, memory, and executive function deficits. MDD was traditionally considered as a neuropsychiatric disorder focused on neuronal dysfunction; however, growing evidence recognizes glial cells, particularly astrocytes, as crucial cells for the pathophysiology and pathogenesis of MDD. Astrocytes play essential roles in the central nervous system, including neurotransmitter uptake, metabolic support, neurotrophic factor production, and synaptic regulation. Evidence from MDD human patients, as well as studies involving animal models have revealed the astrocytic dysfunction as a critical factor in the pathophysiology of MDD, pointing to widespread alterations in astrocyte density, morphology, and function. This review summarizes current knowledge regarding astrocytes and MDD and discuss the potential of targeting astrocytes as a novel avenue for antidepressant development., We are grateful for critical reading to A. SánchezRuiz and A. Prosilis from Perea lab. This work was supported by the Spanish Ministerio de Ciencia e Innovación y Universidades (MICIU) #PID2022-142617NB-I00 and #PLEC2022-009385 MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” to G.P.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder

  • González-Arias, Candela
  • Perea, Gertrudis
Major depressive disorder (MDD) is a global public health concern and the leading cause of disability worldwide. It severely impairs cognitive, emotional, and social functioning, and is associated with attention, memory, and executive function deficits. MDD was traditionally considered as a neuropsychiatric disorder focused on neuronal dysfunction; however, growing evidence recognizes glial cells, particularly astrocytes, as crucial cells for the pathophysiology and pathogenesis of MDD. Astrocytes play essential roles in the central nervous system, including neurotransmitter uptake, metabolic support, neurotrophic factor production, and synaptic regulation. Evidence from MDD human patients, as well as studies involving animal models have revealed the astrocytic dysfunction as a critical factor in the pathophysiology of MDD, pointing to widespread alterations in astrocyte density, morphology, and function. This review summarizes current knowledge regarding astrocytes and MDD and discuss the potential of targeting astrocytes as a novel avenue for antidepressant development., We are grateful for critical reading to A. SánchezRuiz and A. Prosilis from Perea lab. This work was supported by the Spanish Ministerio de Ciencia e Innovación y Universidades (MICIU) #PID2022-142617NB-I00 and #PLEC2022-009385 MICIU/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” to G.P., Peer reviewed